Serum thymic factor prevents LPS-induced pancreatic cell damage in mice via up-regulation of Bcl-2 expression in pancreas

Microbiology and Immunology

Volumn 48, Issue 9, 2004, Pages 629-638

  Saitoh, Noriko ^a,c   Awaya, Akira ^b   Sakudo, Akikazu ^a   SungWook, Seo ^a   Saeki, Keiichi ^a   Matsumoto, Yoshitsugu ^a   Onodera, Takashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; Diabetes; Lipopolysaccharide; Serum thymic factor

Indexed keywords

DNA ANTIBODY; INSULIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NONAPEPTIDE; PROTEIN BCL 2; SINGLE STRANDED DNA; SODIUM CHLORIDE; THYMULIN;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DRUG MECHANISM; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INSULIN SYNTHESIS; MALE; MOUSE; NONHUMAN; PANCREAS; PROTEIN EXPRESSION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL;

ANIMALIA;

EID: 4644356462     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03471.x     Document Type: Article

References (54)

1. Arnush, M., Heitmeier, M.R., Scarim, A.L., Marino, M.H., Manning, P.T., and Corbett, J.A. 1998. IL-1 produced and released endogenously within human islets inhibits β cell function. J. Clin. Invest. 102: 516-526.
2. Bach, M.A., and Beaurain, G. 1979. Respective influence of extrinsic and intrinsic factors on age-related decrease of thymic secretion. J. Immunol. 122: 1056-1058.
3. Bach, J.F., Dardenne, M., Pleau, J.M., and Bach, M.A. 1975. Isolation biochemical characteristic and biological activity of circulating thymic hormone in the mouse and in the human. Ann. N.Y. Acad. Sci. 249: 186-193.
4. Balasa, B., Gunst, K.V., and Sarvetnick, N. 2000. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice. Implications for the etiology of autoimmune diabetes. Clin. Immunol. 95: 93-98.
5. Balasa, B., Krahl, T., Patstone, G., Lee, J., Tisch, R., McDevitt, H.O., and Sarvetnick, N. 1997. CD 40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 159: 4620-4627.
6. Barbu, A., Welsh, N., and Saldeen, J. 2002. Cytokine-induced apoptosis and necrosis are preceded by distraction of the mitochondrial membrane potential (Deltapsi (m) in pancreatic RINm5F cells: prevention by Bcl-2. Mol. Cell. Endocrinol. 25: 75-82.
7. Cailleau, C., Diu-Hercend, A., Ruuth, E., Westwood, R., and Carnaud, C. 1997. Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide induced diabetes in nonobese diabetic mice. Diabetes 46: 937-940.
8. Chervonsky, A.V., Wang, Y., Wong, F.S., Visintin, L., Flavell, R.A., Janeway, C.A., Jr., and Matis, L.A. 1997. The role of Fas in autoimmune diabetes. Cell 89: 17-24.
9. Chomczynski, N., and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Anal. Biochem. 162: 156-159.
10. Corbett, J.A., and McDaniel, M.L. 1995. Intraislet release of IL-1 inhibits beta-cell function by inducing beta-cell expression of iNOS. J. Exp. Med. 181: 559-568.
11. Debray-Sachs, M., Dardenne, M., Sai, P., Savino Quiniou, M.C., Boillot, D., Gepts, W., and Assan, R. 1983. Anti-islet immunity and thymic dysfunction in the mutant diabetic C57BL/KsJ db/db mouse. Diabetes 32: 1048-1054.
12. Dardenne, M., Nabama, B., Lefancier, P., Denien, M., Choay, J., and Bach, J.F. 1982. Contribution of zinc and other metals to the biological activity of the serum thymic factor. Proc. Natl. Acad. Sci. U.S.A. 79: 5370-5373.
13. Delovitch, T.L., and Singh, B. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysfunction gets the NOD. Immunity 7: 727-738.
14. Eizirik, D.L., and Darville, M.I. 2001. Beta-cell apoptosis and defense mechanisms: lessons from type 1 diabetes. Diabetes SO: S64-69.
15. Haddad, J.J., Land, S.C., Saade, N.E., and Safieh-Garabedian, B. 2000. Immunomodulatory potential of thymulin-Zn(2+) in the alveolar epithelium: amelioration of endotoxin-induced cytokine release and partial amplification of a cytoprotective IL-10-sensitive pathway. Biochem. Biophys. Res. Commun. 274: 500-505.
16. Haimovitz-Friedman, A., Cordon-Cardo, C., Bayoumy, S., Garzotto, M., Mcloughlin, M., Gallily, R., Edwards, C.K. 3rd, Schuchman, E.H., Fuks, Z., and Kolesnick, R. 1997. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186: 1831-1841.
17. Iwahashi, H., Hanafusa, T., Eguchi, Y., Nakajima, H., Miyagawa, J., Itoh, N., Tomita, K., Namba, M., Kuwajima, M., Noguchi, T., Tsujimoto, Y., and Matsuzawa, Y. 1996. Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2. Diabetologia 39: 530-536.
18. Iwahashi, H., Itoh, N., Yamagata, K., Nakajima, H., Tomita, K., Moriwaki, M., Waguri, M., Yamamoto, K., Miyagawa, J., Namba, M., Hanafusa, T., and Matsuzawa, Y. 1998. Molecular mechanisms pancreatic beta-cell destruction in autoimmune diabetes: potential targets for preventive therapy. Cytokines Cell Mol. Ther. 4: 45-51.
19. Jiang, Y.F., Vaccaro, M.I., Fiedler, F., Calvo, E.L., and lovanna, J.L. 1999. Lipopolysaccharides induce p8 mRNA expression in vivo and in vitro. Biochem. Biophys. Res. Commun. 260: 686-690.
20. Kawarada, Y., Miura, N., and Sugiyama, T. 1998. Antibody against single-stranded DNA useful for detecting apoptotic cells recognizes hexadeoxynucleotides with various base sequences. J. Biochem. 123: 492-498.
21. Kimura, K., Shimosegawa, T., Abe, R., Masamune, A., Satoh. A., Takasu, A., Koizumi, M., and Toyota, T. 1998. Low doses of lipopolysaccharide upregulate acinar cell apoptosis in cerulein pancreatitis. Pancreas 17: 120-126.
22. Kita, M., Hayashi, T., Yamagishi, H., Oka, T., and Imanishi, J. 1994. Expression of cytokine messenger RNA in human spleen. C.R. Seances Soc. Biol. Fil. 188: 277-282.
23. Kobayashi, S., Iwase, H., Kawarada, Y., Miura, N., Sugiyama, T., Iwata, H., Kara, Y., Omoto, Y., and Nakamura, T. 1998. Detection of DNA fragmentation in human breast cancer tissue by an antibody specific to single-stranded DNA. Breast Cancer 5: 47-52.
24. Lan, M.S., Lu, J., Goto, Y., and Notkins, A.L. 1994. Molecular cloning and identification of receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 13:505-514.
25. Lavine, V.L., Nyman, K.M., Peuravuori, H.J., Henriksen, K., Parvinen, M., and Nevvalainen, T.J. 1996. Lipopolysaccharide induced apoptosis of rat pancreatic acinar cells. Gut 38: 747-752.
26. Leiter, E.H., and Edward, H. 1993. The NOD mouse: a model for analyzing the interplay between heredity and environment in development of autoimmune disease. ILAR News 35: 4-14.
27. Li, P., Allen, H., Bancerjee, S., and Seshadri, T. 1995. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80: 401-411.
28. Maeda, M., Sugiyama, T., Akai, F., Jikihara, I., Hayashi, Y., and Takagi, H. 1998. Single-stranded DNA as an immunocytochemistry marker for apoptotic change of ischemia in gerbil hippocampus. Neurosci. Lett. 240: 69-72.
29. Mandrup-Poulsen, T. 1996. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39: 1005-1029.
30. Mizutani, M., EI-Fotoh, M., Mori, M., Ono, K., Doi, K., Awaya, A., Matsumoto, Y., Matsumoto, Y., and Onodera, T. 1996. In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/cAJ cl mice. Arch. Virol. 141: 73-83.
31. Moore, N.C., Anderson, G., Smith, C.A., Owen, J.J., and Jenkinson, E.J. 1993. Analysis of cytokine gene expression in subpopulations of freshly isolated thymocytes and thymic stromal cells using semiquantitative polymerase chain reaction. Eur. J. Immunol. 23: 922-927.
32. Naruse, I., Keino, H., and Kawarada, Y. 1994. Antibody against single-stranded DNA detects both programmed cell death and drug-induced apoptosis. Histochemistry 101: 73-78.
33. Rabinovitch, A., and Suarez-Pinzon, W.L. 1998. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem. Pharmacol. 55: 1139-1149.
34. Rabinovitch, A. 1998. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab. Rev. 14: 129-151.
35. Rabinovitch, A., Suarez-Pinzon, W., Strynadka, K., Ju, Q., Edelstein, D., Brownlee, M., Korbutt, G.S., and Rajotte, R.V. 1999. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 48: 1223-1229.
36. Reimers, J.I. 1998. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus? Dan. Med. Bull. 4: 157-180.
37. Rollwagen, P.M., Yu, Z.Y., and Pacheco, N.D. 1998. IL-6 rescues enterocytes from hemorrhage induced apoptosis in vivo and in vitro by a bcl-2 mediated mechanism. Clin. Immunol. Immunopathol. 89: 205-213.
38. Savino, W., and Dardenne, M. 2000. Neuroendocrine control of thymus physiology. Endocr. Rev. 21: 412-443.
39. Saldeen, J. 2000. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology 141: 2003-2010.
40. Schindler, R., Mancilla, J., Ghorbani, R., Clark, S.C., and Dinarello, C.A. 1990. Correlation and interactions in the production of interleukin-6 (IL-6), IL-1 and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppress IL-1 and TNF. Blood 75: 40-47.
41. Shimizu, S., Saito, N., Kubosaki, A., Seo, S.W., Takeyama, N., Sakamoto, T., Matsumoto, Y., Saeki, K., Matsumoto, Y., and Onodera, T. 2001. Developmental expression and localization of IA-2 mRNA in mouse neutroendocrine tissue. Biochem. Biophys. Res. Commun. 288: 165-171.
42. Solimena, M., Dirkx, R., Jr., Hermel, J.-M., Pleasic-William, S.A., Shapiro, L., Caron, L., and Rabin, D.U. 1996. ICA512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J. 15: 2102-2114.
43. Sparre, T., Christensen, U.B., Mose-Larsen, P., Fey, S.J., Wrzesinski, K., Roepstorff, P., Mandrup-Poulsen, T, Pociot, F, Karlsen, A.E., and Nerup, J. 2002. IL-1beta induced protein changes in diabetes prone BB rat islets of Langerhans identified by proteome analysis. Diabetologia 45: 1550-1561.
44. Spets, H., Stromberg, T., Georgii-Hemming, P., Siljason, J., Nilsson, K., and Jernberg-Wiklund, H. 2002. Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: regulation during interleukin-6 (IL-6)-induced growth and survival. Eur. J. Haematol. 69: 76-89.
45. Tada, H., Nakashima, A., Awaya, A., Fujisaki, A., Inoue, K., Kawamura, K., Itoh, K., Masuda, H., and Suzuki, T. 2002. Effects of thymic hormone on reactive oxygen species-scavengers and renal function in tacrolimus-induced nephrotoxicity. Life Sci. 70: 1213-1223.
46. Tilg, H., Dinarello, C.A., and Mier, J.W. 1997. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol. Today 18: 428-432.
47. Tran, V.V., Chen, G., Newgard, C.B., and Hohmeier, H.E. 2003. Discrete and complementary mechanisms of protection of beta-cells against cytokine-induced and oxidative damage achieved by bcl-2 overexpression and a cytokine selection strategy. Diabetes 52: 1423-1432.
48. Tumang, J.R., Hsia, C.Y., Tian, W., Bromberg, J.F., and Liou, H. 2002. IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2. Cell Immunol. 217: 47-57.
49. Vaccaro, M.I., Calvo, E.L., Suburo, A.M., Sordelli, D.O., Lanosa, G., and Inovanna, J.L. 2000. Lipopolysaccharide directly affects pancreatic acinar cells: implications on acute pancreatitis pathophysiology. Dig. Dis. Sci. 45: 915-925.
50. Vaccaro, M.I., Dagrosa, M.A., Mora, M.I., Tiscornia, O.M., and Sordelli, D.O. 1996. The effect of chronic intraperitoneal infusion of bacterial endotoxin on exocrine pancreas function in rats. Int. J. Pancreatol. 19: 49-54.
51. Wang, J., Homer, R.J., Chen, Q., and Elias, J.A. 2000. Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J. Immunol. 165: 4051-4061.
52. Ward, N.S., Waxman, A.B., Homer, R.J., Mantell, L.L., Einarsson, O., Du, Y., and Elias, J.A. 2000. Interleukin-6-induced protection in hyperoxic acute lung injury. J. Respir. Cell Mol. Biol. 22: 535-542.
53. Yamanouchi, T., Moromizato, H., Kojima, S., Shinohara, T., Sekino, N., Minoda, S., Miyashita, H., and Akaoka, I. 1994. Prevention of diabetes by thymic hormone in alloxan-treated rats. Eur. J. Pharmacol. 257: 39-46.
54. Yasuda, J., Nishioka, W., Sakudo, A., Yama, S., Setoguchi, R., Saeki, K., Matsumoto, Y., Awaya, A., and Onodera, T. 2003. Suppressor mechanism of serum thymic factor on tumor necrosis factor-α-induced apoptosis in the mouse pancreatic β-cell line. Biochem. Biophys. Res. Commun. 311: 501-505.